Drawing for MICROMEDICINE

USPTO serial 87074988

MICROMEDICINE

Reviewed by CopyMark Law Group

Reg. 6024409Status 710
Filing date
Status date
Registration date
Mar 31, 2020
Examiner
SOMERVILLE, ARETHA CHARESE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MICROMEDICINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua S. Jarvis

Joshua S. Jarvis Foley Hoag LLP155 Seaport Blvd.Boston, MA 02210-2600UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Electromechanical device, namely, cell isolation and concentration systems comprised of electromechanical instruments to drive fluids into consumable microfluidic chips for use in clinical and laboratory researchSECTION 8 - CANCELLEDJan 28, 2020
010Medical devices, namely, electromechanical fluidic instruments, and other similar or related devices, which process complex human body fluids; Medical diagnostic and therapeutic instruments for the processing of body fluids and the isolation and concentration of components thereof; Medical machinery, namely, cell isolation and concentration systems comprised of electromechanical instruments to drive fluids into consumable microfluidic chips for use in the separation and isolation of complex body fluids for the purposes of diagnostics, therapeutics, regenerative medical treatment, transfusions, and clinical and laboratory research; cell isolation and concentration system comprised of electromechanical instruments to drive fluids into consumable microfluidic chips that employs microfluidic technology for processing complex body fluidsSECTION 8 - CANCELLEDJan 28, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026C8..CANCELLED SEC. 8 (6-YR)—
Mar 31, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 6, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 6, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 6, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 6, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 6, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Aug 25, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 17, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Mar 10, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 11, 2020WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Sep 11, 2020WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Mar 31, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 25, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 22, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 18, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 18, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 31, 2020IUAFUSE AMENDMENT FILED—
Jan 31, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 23, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 19, 2019EX4GSOU EXTENSION 4 GRANTED—
Jul 19, 2019EXT4SOU EXTENSION 4 FILED—
Jul 19, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 31, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2019EX3GSOU EXTENSION 3 GRANTED—
Jan 29, 2019EXT3SOU EXTENSION 3 FILED—
Jan 29, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 11, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 9, 2018EX2GSOU EXTENSION 2 GRANTED—
Jul 9, 2018EXT2SOU EXTENSION 2 FILED—
Jul 9, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 7, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 7, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 5, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 3, 2018EX1GSOU EXTENSION 1 GRANTED—
Jan 3, 2018EXT1SOU EXTENSION 1 FILED—
Jan 3, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 22, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 27, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 27, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 22, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 12, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 12, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 3, 2017ALIEASSIGNED TO LIE—
Apr 17, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 20, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 20, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 20, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 21, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 5, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 4, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 4, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 3, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2016DOCKASSIGNED TO EXAMINER—
Jun 23, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jun 22, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 21, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance